Latest Breaking News On - Fabre kramer pharmaceuticals - Page 2 : comparemela.com

FDA approves new medication for Major Depressive Disorder (MDD)

FDA approves new medication for Major Depressive Disorder (MDD)
iol.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iol.co.za Daily Mail and Mail on Sunday newspapers.

Fabre kramer pharmaceuticalsScience directMajor depressive disorder

FDA Approves Gepirone (Exxua) for Major Depressive Disorder

Gepirone, sold under the brand name Exxua, does not cause sexual dysfunction or weight gain, unlike other antidepressants.

United statesBaylor college of medicineSan diegoSanjay mathewStephen stahlNational institute of mental healthFabre kramer pharmaceuticalsNeuroscience education instituteDepression association of americaMajor health problemUniversity of californiaDrug administrationNeuroscience educationDepression associationBaylor collegeAdditional therapeutic option

Exxua, a Novel Treatment for Major Depressive Disorder, Gets FDA Approval

The FDA has approved Exxua (gepirone HCl extended-release tablets) for the treatment of major depressive disorder in adults.

Fabre kramer pharmaceuticalsDrug administrationHamilton depression rating scaleBoxed warningKramer pharmaceuticals

FDA approves antidepressant not linked to sexual dysfunction, weight gain

FDA approves antidepressant not linked to sexual dysfunction, weight gain
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesHeather bieleStephen kramerStephenm stahlNeuroscience education instituteFabre kramer pharmaceuticalsUniversity of california

FDA approves first-in-class antidepressant

FDA approves first-in-class antidepressant
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

United statesStephen kramerStephen stahlAnita claytonNeuroscience education instituteDrug administrationFabre kramer pharmaceuticalsBipolar support allianceUniversity of virginia school medicineDepartment of psychiatry neurobehavioral sciencesUniversity of californiaNeuroscience educationMichael pollackChief executive officerNeurobehavioral sciences